The jury agreed with Axonics, opens new tab on Wednesday that its R15 neurostimulation system did not infringe Medtronic patents related to its own devices, which are used to treat incontinence ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence ... support urinary and bowel control. At the time, Medtronic said the findings ...

Medtronic (MDT) is a billion-dollar global ... Neuroscience products also treat overactive bladder, urinary retention, and fecal incontinence. It also produces products for the ear, nose, and ...

As far we know, this is the first published tined lead implantation which was guided based on the surgical navigation and intraoperative O-arm images. The method is slightly more invasive than the ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive deep brain stimulation, a technology that’s currently under review ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Experiencing incontinence might feel embarrassing, but Priya Padmanabhan, M.D., wants people to know it is a normal part of aging. She knows what she’s talking about: Dr. Padmanabhan is an ...

Medtronic has published preliminary data from a study of its adaptive deep brain stimulation (aDBS) device, Percept PC neurostimulator, in patients living with Parkinson’s disease. The adaptive ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...